http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0971538-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ddd4d1d0ebc8a7d2c8e7d214d08cf3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 1995-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf06c6f4813a04af3b9f076ca087966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9e90f4591352d28b6455891f2fd7609 |
| publicationDate | 1997-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0971538-A |
| titleOfInvention | Prurigo remedies |
| abstract | (57) [Abstract] [Problem] To provide a therapeutic agent for prurigo. SOLUTION: In order to use IFN-γ as a therapeutic agent for prurigo, 250,000 to 4,000,000 JRU per day is preferably administered once, divided into several times according to the symptoms and side effects, and systemically administered, preferably. Is administered intravenously, more preferably intravenous drip. The dosage and administration can be changed according to the medical condition and age. [Effect] IFN-γ is extremely effective for the treatment of prurigo. The mechanism of action is presumed to be involved in the action of IFN-γ that normalizes the imbalance of peripheral lymphocytes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2004058295-A1 |
| priorityDate | 1995-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.